Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors.
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.
Deep molecular characterization of HIV-1 dynamics under suppressive HAART.
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
Exosomes and retroviruses: the chicken or the egg?